Active ingredientMazindolCat. No. P-M017-001CAS 22232-71-9Family · Pharmaceutical analytical standards
Mazindol
A sympathomimetic amine with a tricyclic imidazoisoindole structure, developed in the 1960s and approved in the United States in June 1973 as an appetite suppressant for the short-term treatment of obesity; it has also been studied for narcolepsy and ADHD. This family brings together the active ingredient.
Did you know?Its molecule changes shape with acidity: depending on pH it switches between a keto form and a closed cyclic form, a hemiaminal, in an equilibrium called tautomerism.
Go to the active ingredient →Active ingredientMazindolCat. No. P-M017-001CAS 22232-71-9No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.